4.2 Read 115 reviews
Featured byUniversity of Birmingham
Overview
Key facts
It has not only transformed scientific thinking of how our bodies can respond to cancer but has also shown us that it can be possible to tackle cancers we previously viewed as untreatable. Regarded as a breakthrough area in the treatment of cancer, immunotherapies can be seen as a way to ‘turn our immune response up to 11’. Particularly, immune checkpoint blockade has taken cancer immunotherapy from a pipedream to a pipeline of new therapeutics. This type of therapy works by activating a person’s immune system – but how? When does and doesn’t it work? What are the potential side effects and how can it be optimised?
University of Birmingham's Understanding immune checkpoint blockade therapy - a pillar of modern cancer treatment programme will teach you more about this topic.
Programme Structure
Courses include:
- A critical focus on a vital aspect of cancer treatment based on academic, healthcare and patient perspectives.
- A chance to explore fascinating cutting-edge science that has transformed our understanding of cancer treatment and countless lives.
- A unique insight into lived experiences of patients and a profound understanding of its impact.
- A forward-looking view of the diverse and fast-paced developments in immune checkpoint blockade therapy.
- Certificate of Participation once the quiz is completed Certificate of Attendance with no quiz entry.
Key information
Duration
- Part-time
- 2 months
Start dates & application deadlines
You can apply for and start this programme anytime.
Language
English
Delivered
Online
Disciplines
Health Sciences View 323 other Short Courses in Health Sciences in United KingdomAcademic requirements
We are not aware of any specific GRE, GMAT or GPA grading score requirements for this programme.
English requirements
We are not aware of any English requirements for this programme.
Other requirements
General requirements
This course has been expertly informed by scientists, clinicians and patients to provide a basic understanding of immune checkpoint blockade therapies to a range of audiences. It is designed to benefit healthcare professionals, individuals working in industry, oncologists and cancer specialists, non-cancer specialists such as geneticists and basic immunologists, as well as patient groups and students (MSc, medical and undergraduates) with a background in science.
Tuition Fee
To always see correct tuition fees
-
International
250 GBP/fullTuition FeeBased on the tuition of 250 GBP for the full programme during 2 months. -
National
250 GBP/fullTuition FeeBased on the tuition of 250 GBP for the full programme during 2 months.
Funding
Improve page content